Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
n-Lorem, a nonprofit founded by Dr. Stanley Crooke, develops antisense oligonucleotide therapies for patients with nano-rare diseases, including KIF1A-associated neurological disorder (KAND). The organization provides these treatments free for life, addressing a critical gap in care for patients with rare genetic mutations.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.